<?xml version='1.0' encoding='utf-8'?>
<document id="31581860"><sentence text="Cardiovascular Outcomes Associated With Clinical Use of Citalopram and Omeprazole: A Nationwide Population-Based Cohort Study."><entity charOffset="56-66" id="DDI-PubMed.31581860.s1.e0" text="Citalopram" /><entity charOffset="71-81" id="DDI-PubMed.31581860.s1.e1" text="Omeprazole" /><pair ddi="false" e1="DDI-PubMed.31581860.s1.e0" e2="DDI-PubMed.31581860.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31581860.s1.e0" e2="DDI-PubMed.31581860.s1.e1" /></sentence><sentence text="Background Recent studies have raised concerns about the reduced efficacy of citalopram when used concurrently with proton pump inhibitors"><entity charOffset="77-87" id="DDI-PubMed.31581860.s2.e0" text="citalopram" /></sentence><sentence text=" The aim of this study was to evaluate the associations between clinical use of citalopram and omeprazole and the risk of sudden cardiac arrest (SCA) in an Asian population"><entity charOffset="80-90" id="DDI-PubMed.31581860.s3.e0" text="citalopram" /><entity charOffset="95-105" id="DDI-PubMed.31581860.s3.e1" text="omeprazole" /><pair ddi="false" e1="DDI-PubMed.31581860.s3.e0" e2="DDI-PubMed.31581860.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31581860.s3.e0" e2="DDI-PubMed.31581860.s3.e1" /></sentence><sentence text=" Methods and Results A retrospective cohort study was conducted using the National Health Insurance Research Database of Taiwan dated from 2000 to 2013" /><sentence text=" The study cohorts comprised 3882 patients with citalopram use alone, 31 090 patients with omeprazole use alone, and 405 patients with concomitant use of citalopram and omeprazole (as the exposed cohort), and 141 508 patients received treatment with antidepressants without the risk of SCA and/or proton pump inhibitors other than omeprazole (as the comparison cohort)"><entity charOffset="48-58" id="DDI-PubMed.31581860.s5.e0" text="citalopram" /><entity charOffset="91-101" id="DDI-PubMed.31581860.s5.e1" text="omeprazole" /><entity charOffset="154-164" id="DDI-PubMed.31581860.s5.e2" text="citalopram" /><entity charOffset="169-179" id="DDI-PubMed.31581860.s5.e3" text="omeprazole" /><entity charOffset="331-341" id="DDI-PubMed.31581860.s5.e4" text="omeprazole" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e0" e2="DDI-PubMed.31581860.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e0" e2="DDI-PubMed.31581860.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e0" e2="DDI-PubMed.31581860.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e0" e2="DDI-PubMed.31581860.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e0" e2="DDI-PubMed.31581860.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e1" e2="DDI-PubMed.31581860.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e1" e2="DDI-PubMed.31581860.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e1" e2="DDI-PubMed.31581860.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e1" e2="DDI-PubMed.31581860.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e2" e2="DDI-PubMed.31581860.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e2" e2="DDI-PubMed.31581860.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e2" e2="DDI-PubMed.31581860.s5.e4" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e3" e2="DDI-PubMed.31581860.s5.e3" /><pair ddi="false" e1="DDI-PubMed.31581860.s5.e3" e2="DDI-PubMed.31581860.s5.e4" /></sentence><sentence text=" The primary outcome was the occurrence of SCA" /><sentence text=" The hazard ratios and 95% CIs derived from the time-dependent Cox regression model were used to assess the association between the proposed drug treatments and risk of SCA" /><sentence text=" The adjusted hazard ratios of SCA was 1" /><sentence text="32 (95% CI, 1" /><sentence text="17-1" /><sentence text="50) for citalopram use alone, 1"><entity charOffset="8-18" id="DDI-PubMed.31581860.s11.e0" text="citalopram" /></sentence><sentence text="08 (95% CI, 0" /><sentence text="98-1" /><sentence text="20) for omeprazole use alone, and 2"><entity charOffset="8-18" id="DDI-PubMed.31581860.s14.e0" text="omeprazole" /></sentence><sentence text="23 (95% CI, 1" /><sentence text="79-2" /><sentence text="78) for concomitant use of citalopram and omeprazole"><entity charOffset="27-37" id="DDI-PubMed.31581860.s17.e0" text="citalopram" /><entity charOffset="42-52" id="DDI-PubMed.31581860.s17.e1" text="omeprazole" /><pair ddi="false" e1="DDI-PubMed.31581860.s17.e0" e2="DDI-PubMed.31581860.s17.e0" /><pair ddi="false" e1="DDI-PubMed.31581860.s17.e0" e2="DDI-PubMed.31581860.s17.e1" /></sentence><sentence text=" The cumulative incidence of SCA over the Kaplan-Meier curves was more pronounced in patients with concomitant use of citalopram and omeprazole than those treated with citalopram alone and omeprazole alone"><entity charOffset="118-128" id="DDI-PubMed.31581860.s18.e0" text="citalopram" /><entity charOffset="133-143" id="DDI-PubMed.31581860.s18.e1" text="omeprazole" /><entity charOffset="168-178" id="DDI-PubMed.31581860.s18.e2" text="citalopram" /><entity charOffset="189-199" id="DDI-PubMed.31581860.s18.e3" text="omeprazole" /><pair ddi="false" e1="DDI-PubMed.31581860.s18.e0" e2="DDI-PubMed.31581860.s18.e0" /><pair ddi="false" e1="DDI-PubMed.31581860.s18.e0" e2="DDI-PubMed.31581860.s18.e1" /><pair ddi="false" e1="DDI-PubMed.31581860.s18.e0" e2="DDI-PubMed.31581860.s18.e2" /><pair ddi="false" e1="DDI-PubMed.31581860.s18.e0" e2="DDI-PubMed.31581860.s18.e3" /><pair ddi="false" e1="DDI-PubMed.31581860.s18.e1" e2="DDI-PubMed.31581860.s18.e1" /><pair ddi="false" e1="DDI-PubMed.31581860.s18.e1" e2="DDI-PubMed.31581860.s18.e2" /><pair ddi="false" e1="DDI-PubMed.31581860.s18.e1" e2="DDI-PubMed.31581860.s18.e3" /><pair ddi="false" e1="DDI-PubMed.31581860.s18.e2" e2="DDI-PubMed.31581860.s18.e2" /><pair ddi="false" e1="DDI-PubMed.31581860.s18.e2" e2="DDI-PubMed.31581860.s18.e3" /></sentence><sentence text=" Conclusions This cohort study demonstrated use of citalopram and omeprazole either in isolation use or in concomitant use to be at increased risk for SCA"><entity charOffset="51-61" id="DDI-PubMed.31581860.s19.e0" text="citalopram" /><entity charOffset="66-76" id="DDI-PubMed.31581860.s19.e1" text="omeprazole" /><pair ddi="false" e1="DDI-PubMed.31581860.s19.e0" e2="DDI-PubMed.31581860.s19.e0" /><pair ddi="false" e1="DDI-PubMed.31581860.s19.e0" e2="DDI-PubMed.31581860.s19.e1" /></sentence><sentence text="" /></document>